151 related articles for article (PubMed ID: 28653617)
1. Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Shan X; Fung JJ; Kosaka A; Danet-Desnoyers G;
Elife; 2017 Jun; 6():. PubMed ID: 28653617
[TBL] [Abstract][Full Text] [Related]
2. Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia.
Fung JJ; Kosaka A; Shan X; Danet-Desnoyers G; Gormally M; Owen K; ;
Elife; 2015 Sep; 4():. PubMed ID: 26327698
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Dawson MA; Prinjha RK; Dittmann A; Giotopoulos G; Bantscheff M; Chan WI; Robson SC; Chung CW; Hopf C; Savitski MM; Huthmacher C; Gudgin E; Lugo D; Beinke S; Chapman TD; Roberts EJ; Soden PE; Auger KR; Mirguet O; Doehner K; Delwel R; Burnett AK; Jeffrey P; Drewes G; Lee K; Huntly BJ; Kouzarides T
Nature; 2011 Oct; 478(7370):529-33. PubMed ID: 21964340
[TBL] [Abstract][Full Text] [Related]
4. Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Aird F; Kandela I; Mantis C;
Elife; 2017 Jan; 6():. PubMed ID: 28100400
[TBL] [Abstract][Full Text] [Related]
5. Replication Study: Melanoma genome sequencing reveals frequent
Horrigan SK; Courville P; Sampey D; Zhou F; Cai S;
Elife; 2017 Jan; 6():. PubMed ID: 28100394
[TBL] [Abstract][Full Text] [Related]
6. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Mantis C; Kandela I; Aird F;
Elife; 2017 Jan; 6():. PubMed ID: 28100395
[TBL] [Abstract][Full Text] [Related]
7. Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data.
Kandela I; Aird F;
Elife; 2017 Jan; 6():. PubMed ID: 28100397
[TBL] [Abstract][Full Text] [Related]
8. Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Horrigan SK;
Elife; 2017 Jan; 6():. PubMed ID: 28100392
[TBL] [Abstract][Full Text] [Related]
9. Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells.
Vanden Heuvel JP; Maddox E; Maalouf SW;
Elife; 2018 Jan; 7():. PubMed ID: 29313488
[TBL] [Abstract][Full Text] [Related]
10. Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Kandela I; Jin HY; Owen K;
Elife; 2015 Jun; 4():e07072. PubMed ID: 26111384
[TBL] [Abstract][Full Text] [Related]
11. Replication study: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Kim J; Afshari A; Sengupta R; Sebastiano V; Gupta A; Kim YH;
Elife; 2018 Dec; 7():. PubMed ID: 30526855
[TBL] [Abstract][Full Text] [Related]
12. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Kerwin J; Khan I;
Elife; 2020 Apr; 9():. PubMed ID: 32314732
[TBL] [Abstract][Full Text] [Related]
13. Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
Sheen MR; Fields JL; Northan B; Lacoste J; Ang LH; Fiering S;
Elife; 2019 Dec; 8():. PubMed ID: 31845647
[TBL] [Abstract][Full Text] [Related]
14. The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity.
Liu A; Fan D; Wang Y
Cell Tissue Res; 2018 Dec; 374(3):577-585. PubMed ID: 30182276
[TBL] [Abstract][Full Text] [Related]
15. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
16. BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells.
Schilderink R; Bell M; Reginato E; Patten C; Rioja I; Hilbers FW; Kabala PA; Reedquist KA; Tough DF; Tak PP; Prinjha RK; de Jonge WJ
Mol Immunol; 2016 Nov; 79():66-76. PubMed ID: 27710838
[TBL] [Abstract][Full Text] [Related]
17. Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
Wang H; Radomska HS; Phelps MA;
Elife; 2020 Oct; 9():. PubMed ID: 33073769
[TBL] [Abstract][Full Text] [Related]
18. Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota.
Eaton K; Pirani A; Snitkin ES;
Elife; 2018 Oct; 7():. PubMed ID: 30295289
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
Seal J; Lamotte Y; Donche F; Bouillot A; Mirguet O; Gellibert F; Nicodeme E; Krysa G; Kirilovsky J; Beinke S; McCleary S; Rioja I; Bamborough P; Chung CW; Gordon L; Lewis T; Walker AL; Cutler L; Lugo D; Wilson DM; Witherington J; Lee K; Prinjha RK
Bioorg Med Chem Lett; 2012 Apr; 22(8):2968-72. PubMed ID: 22437115
[TBL] [Abstract][Full Text] [Related]
20. Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
Essex A; Pineda J; Acharya G; Xin H; Evans J;
Elife; 2019 Jun; 8():. PubMed ID: 31215867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
